共 42 条
[41]
FDA GRANTS MARKETING LICENSE FOR POLYCLONAL ANTIBODY THAT TARGETS RH BLOOD-TYPE INCOMPATIBILITY - WILL BE SOLD IN US BY UNIVAX-BIOLOGICS
[J].
BIOTECHNOLOGY LAW REPORT,
1995, 14 (02)
:328-329